These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9401667)

  • 21. The effects of alpha 2-adrenoceptor stimulation on neocortical EEG activity in control and 6-hydroxydopamine dorsal noradrenergic bundle-lesioned rats.
    Riekkinen P; Lammintausta R; Ekonsalo T; Sirviö J
    Eur J Pharmacol; 1993 Jul; 238(2-3):263-72. PubMed ID: 8104809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sympatholytic and minimum anesthetic concentration-sparing responses are preserved in rats rendered tolerant to the hypnotic and analgesic action of dexmedetomidine, a selective alpha(2)-adrenergic agonist.
    Rabin BC; Reid K; Guo TZ; Gustafsson E; Zhang C; Maze M
    Anesthesiology; 1996 Sep; 85(3):565-73. PubMed ID: 8853087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid reversal of alpha 2-adrenoceptor agonist effects by atipamezole in human volunteers.
    Karhuvaara S; Kallio A; Salonen M; Tuominen J; Scheinin M
    Br J Clin Pharmacol; 1991 Feb; 31(2):160-5. PubMed ID: 1675577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of serotonergic neurotransmission in the hypnotic response to dexmedetomidine, an alpha 2-adrenoceptor agonist.
    Rabin BC; Guo TZ; Gregg K; Maze M
    Eur J Pharmacol; 1996 Jun; 306(1-3):51-9. PubMed ID: 8813614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective and segmentally restricted antinociception induced by MPV-2426, a novel alpha-2-adrenoceptor agonist, following intrathecal administration in the rat.
    Onttonen T; Kalmari J; Pertovaara A
    Acta Anaesthesiol Scand; 2000 Oct; 44(9):1077-82. PubMed ID: 11028726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dexmedetomidine as intramuscular premedication in outpatient cataract surgery. A placebo-controlled dose-ranging study.
    Virkkilä M; Ali-Melkkilä T; Kanto J; Turunen J; Scheinin H
    Anaesthesia; 1993 Jun; 48(6):482-7. PubMed ID: 8100688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dexmedetomidine does not modify the neuromuscular blocking action of vecuronium in the anaesthetized rat.
    Weinger MB; Partridge BL; Henry AF
    Br J Anaesth; 1995 Apr; 74(4):455-7. PubMed ID: 7734268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of selective alpha 2-adrenergic agents on mustard oil-induced central hyperalgesia in rats.
    Mansikka H; Pertovaara A
    Eur J Pharmacol; 1995 Jul; 281(1):43-8. PubMed ID: 8566115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dexmedetomidine reduces response tendency, but not accuracy of rats in attention and short-term memory tasks.
    Ruotsalainen S; Haapalinna A; Riekkinen PJ; Sirviö J
    Pharmacol Biochem Behav; 1997 Jan; 56(1):31-40. PubMed ID: 8981606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A hypnotic response to dexmedetomidine, an alpha 2 agonist, is mediated in the locus coeruleus in rats.
    Correa-Sales C; Rabin BC; Maze M
    Anesthesiology; 1992 Jun; 76(6):948-52. PubMed ID: 1350889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroendocrine effects of dexmedetomidine: evidence of cross-tolerance between a mu-opioid agonist and an alpha 2-adrenoceptor agonist in growth hormone secretion of the male rat.
    Idänpään-Heikkilä JJ; Rauhala P; Männistö PT
    Pharmacol Toxicol; 1996 Mar; 78(3):136-42. PubMed ID: 8882345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dexmedetomidine injection into the locus ceruleus produces antinociception.
    Guo TZ; Jiang JY; Buttermann AE; Maze M
    Anesthesiology; 1996 Apr; 84(4):873-81. PubMed ID: 8638842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attenuation of ethanol withdrawal signs by high doses of L-arginine in rats.
    Uzbay IT; Erden BF
    Alcohol Alcohol; 2003; 38(3):213-8. PubMed ID: 12711654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of fluoxetine on ethanol withdrawal syndrome in rats.
    Uzbay IT; Sağ Lam E; Kayir H; Celik T; Beyazyürek M
    J Psychiatr Res; 2004; 38(4):445-50. PubMed ID: 15203297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dexmedetomidine, a selective alpha 2-agonist, does not potentiate the cardiorespiratory depression of alfentanil in the rat.
    Furst SR; Weinger MB
    Anesthesiology; 1990 May; 72(5):882-8. PubMed ID: 1971163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antinociceptive actions of dexmedetomidine and the kappa-opioid agonist U-50,488H against noxious thermal, mechanical and inflammatory stimuli.
    Idänpään-Heikkilä JJ; Kalso EA; Seppälä T
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1306-13. PubMed ID: 7996439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute and chronic tianeptine treatments attenuate ethanol withdrawal syndrome in rats.
    Uzbay T; Kayir H; Celik T; Yüksel N
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):478-85. PubMed ID: 16412550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies with alpha 2-adrenoceptor agonists and alcohol abstinence syndrome in rats.
    Parale MP; Kulkarni SK
    Psychopharmacology (Berl); 1986; 88(2):237-9. PubMed ID: 2869542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Desensitization to the behavioral effects of alpha 2-adrenergic agonists in rats.
    Hayashi Y; Guo TZ; Maze M
    Anesthesiology; 1995 Apr; 82(4):954-62. PubMed ID: 7717568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of allyphenyline efficacy in the treatment of alcohol withdrawal symptoms.
    Ubaldi M; Del Bello F; Domi E; Pigini M; Nasuti C
    Eur J Pharmacol; 2015 Aug; 760():122-8. PubMed ID: 25895641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.